twitter Tweet

Dr. Francis quoted on stem cell therapy

Dr. FrancisThe New York Times has reported on new treatments for retina disease being developed by two companies. One of the companies, Advanced Cell Technology, said it would test its stem cell therapy on 12 adults with severe vision loss. OHSU will be a site for the trial. In the article, Peter Francis, MD, Associate Professor, Department of Ophthalmology, was quoted as saying, “the eye is a good place to test stem cell therapy because it is accessible.” He also said, “There is less chance of rejection of the implanted cells because the eye is shielded somewhat from the body’s immune system.” The complete article is available at nytimes.com.  A similar article can be found at usatoday.com

Previous Story The Oregonian welcomes Knight Cancer Institute’s growth, notes important role in community Next Story Drs. Kinzie and Leung weigh in on struggles of Iraqi immigrants
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X